TG Therapeutics Inc at Jefferies Virtual London Healthcare Conference Transcript
Hi, everybody. Thank you so much for joining our Virtual London Healthcare Conference this year. My name is Chris Howerton, part of the Jefferies biotechnology research team. Very pleased to be hosting a fireside chat with the next company, TG Therapeutics. And on behalf of the company is CEO Mike Weiss. So thanks for joining us, Mike.
Thanks, Chris. Thanks for having us.
Questions & Answers
Absolutely. So I think it's been obviously a hell of a year for a variety of reasons, but I think for you guys, it's been coming down to this, this time, right? I mean this is a big period of time for the company. So I think we have obviously a big event in just, what is it, in a couple of weeks at ASH, and then, of course, the big news for the MS program. So maybe why don't we start off with ASH?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |